Mad in America

JANUARY 4, 2025

American psychiatry has weathered the crisis; it will not have to confront a public stunned by news of how the oft-cited 67% cumulative remission rate, in the largest and longest study ever done to evaluate depression treatment,” was born of scientific misconduct. Short of this, the best remaining course to take is a retraction.”

Pharmaceuticals 145

Pharmaceuticals Neurotransmitters and mental health Sleep and mental health Aging and mental health 145

Mad in America

JANUARY 3, 2024

The NIMH ran advertisements in the media, and Eli Lilly helped pay for the printing and distribution of 8 million DART brochures titled “Depression: What You Need to Know.” This pamphlet informed readers of the particular merits of “serotonergic” drugs for the disease. “By Rush was named the lead investigator of the $35 million effort.

Neurotransmitters and mental health 144

Neurotransmitters and mental health Hospitality Education Self-awareness 144

Zencare

JANUARY 22, 2025

There are 298 mental health conditions currently recognized in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition-TR, which is the standard reference for clinical practice among trained, licensed mental health professionals, in the US. Written by Rebekah Ferguson, LMHC.

Neurotransmitters and mental health 52

Neurotransmitters and mental health Bipolar disorder Sleep and mental health Genetics and mental health 52

Mad in America

NOVEMBER 6, 2023

667 In an NIMH study of 547 patients that compared six-year outcomes for depressed people treated for the disorder and those who eschewed medical treatment, the treated patients were three times more likely than untreated ones to suffer a cessation of their principal social role and nearly seven times more likely to become incapacitated.

Bipolar disorder 145

Bipolar disorder Neurotransmitters and mental health Genetics and mental health Pharmaceuticals 145